Two experiments were conducted to explore the effects of a sodium saccharin-based dietary sweetener (Sucram) on growth performance, health, and physiological responses of feedlot steers. In Exp. 1, 173 newly-received male calves purchased from auction barns were fed 0, 100, 200, or 300 g of Sucram/t of DM over 56 d. Overall, ADG and G:F (P > 0.10) were not different among treatments, but steers receiving 200 g Sucram/t displayed numerically greater ADG (23%). In addition, DMI was 17% greater for steers receiving 200 g of Sucram/t compared to steers fed the control diet (cubic effect, P = 0.09). The morbidity rate for respiratory disease did not differ (P > 0.50) among treatments. In Exp. 2, 15 steers (initial BW = 261 ± 28 kg) were used to evaluate the effects of Sucram on apparent total tract digestibility, plasma metabolite concentrations, and urine monoamine metabolite concentrations. Treatments consisted of ad libitum access to a 60% concentrate diet (Control), ad libitum access to Control + 200 g of Sucram/t of DM (Adlib), and Control + 200 g of Sucram/t of DM with feed intake paired to the Control (Paired). By design, steer DMI during the metabolism period did not differ (P = 0.34) between Paired and Control, but DMI tended (P = 0.14) to be 8.2% greater for Adlib than for Control. Treatments did not alter (P > 0.17) apparent total tract nutrient digestibility. Postprandial plasma citrulline concentration was lower (P = 0.03) for Adlib than for Control and tended to be lower (P = 0.13) for Paired than for Control. Plasma homocysteine concentration was reduced (P < 0.03) by feeding Sucram. Urinary concentrations of ethylmalonic acid, vanillymandelic acid, and 5-hydroxyindolacetic acid were greater (P < 0.06) for Adlib than for Control; Paired steers had a greater (P = 0.02) urine vanillymandelic acid concentration than Control steers and tended (P < 0.12) to have a greater urinary concentration of ethylmalonic and 5-hydroxyindolacetic acid than Control steers. Serum insulin was greater for Adlib than for Control steers (P = 0.04) and tended to be greater for Paired than for Control steers (P = 0.14), but serum prolactin area did not differ (P > 0.22) among treatments. Supplementation with Sucram may increase feed intake by newly-received, stressed feedlot calves. Saccharin supplementation reduced plasma homocysteine and increased urinary excretion of vanillymandelic acid, suggesting an improved activity of the dopamine reward system.
INTRODUCTION
indicated that low feed intake by stressed calves the first 14 d is a significant impediment to improving their health and performance. Preference tests and neurophysiological studies report that some sweeteners elicit taste nerve receptor responses in calves (Hård af Segerstad and Hellekant, 1989; Hellekant et al., 1994) . One such palatant containing sodium saccharin is commercially available as SUCRAM C-150 (Pancosma SA, Le Grand Saconnex, Switzerland).
Saccharin has been reported to be largely unabsorbed from the rat gastrointestinal tract (Renwick, 1985) . Although saccharin seems to be resistant to measurable postabsorptive metabolism (Lethco and Wallace, 1975) , absorbed saccharin seems to be eliminated rapidly and primarily in the urine (Renwick, 1985) . Thus, direct and indirect influences of saccharin on animal metabolism and physiology are anticipated. McMeniman et al. (2006) reported that healthy calves did not preferentially select a Sucram-containing diet. Newly-received, stressed beef calves that were fed 200 g of Sucram/t of DM tended to have 5.4% greater DMI from d 29 to 56 on feed, but overall (d 1 to 56) DMI was not altered by feeding Sucram. The objectives of our work were to explore potential dose-and time-dependent effects of Sucram on morbidity and growth performance of stressed calves and to assess nutrient digestibility, plasma metabolite and hormone concentrations, and monoamine metabolite excretion by healthy steer calves.
MATERIALS AND METHODS
Experimental procedures were reviewed and approved by the Amarillo-Area Cooperative Research, Education, and Extension Triangle Animal Care and Use Committee (protocol numbers 2002-29 and 2003-29) .
Experiment 1
One-hundred seventy-three male calves (75% bulls) were delivered from Camden, AR, to the study site in Canyon, TX, in 2 separate loads in July. Animals were processed on arrival, and processing included identification; weighing; vaccination against viral antigens IBR, BVD type I and II (Titanium 3; Agri Laboratories, St. Joseph, MO), and clostridial toxoids (Covexin 8; Merck Animal Health); treatment for internal and external parasites with 0.1 mL/kg BW of 5 mg moxidectin/mL (Cydectin; Pfizer Animal Health, Exton, PA); implanting with 36 mg of zeranol (Ralgro; Merck Animal Health); castration of intact males by banding; horn tipping to a diameter of 2 cm; and treatment with 3.0 mL/45.4 kg of BW s.c. of tilmicosin phosphate (Micotil; Elanco Animal Health, Indianapolis, IN) as needed based on rectal temperature (> 39.9°C). Animals within a load were sorted into 4 groups as they exited the chute based on castration and horn tipping (castrated bulls with tipped horns, castrated bulls without tipped horns, steers with tipped horns, and steers without tipped horns). Following processing, animals within a load were allocated randomly to study pens by removing 1 or 2 animals from each group until each pen contained 11 animals.
Sucram (SUCRAM C-150; Pancosma SA, Le GrandSaconnex, Switzerland) was incorporated into meal-form supplements using a stationary ribbon mixer (Model S-3; H.C. Davis Sons Manufacturing Co., Bonner Springs, KS) to deliver 0, 100, 200, or 300 g of Sucram/t of diet DM. Calves were fed 50%, 65%, 75%, and 82.5% concentrate diets (based on steam-flaked corn) for 15, 4, 10, and 5 d, respectively, and a 90% concentrate diet for the final 22 d of the 56-d study (Table 1) . Basal diets were manufactured once daily using a stationary paddle mixer (Model 84-4; Roto-mix, Inc., Dodge City, KS). Calves were also allowed ad libitum access to prairie hay for the first week; the ration was delivered on top of the hay in the bunk. Individual BW was determined before feeding after 7 (including revaccination for IBR and PI3; Nasalgren IP; Merck Animal Health, Summit, NJ), 14, 21, and 28 d. After 56 d, cattle were weighed after feed and water had been removed for 24 and 12 h, respectively. All BW measurements were acquired using a single-animal scale (LBS Scales; LBS Inc., Garden City, KS; readability ± 0.45 kg). The scale was validated before each use using 454 kg of certified (Texas Department of Agriculture) weights and calibrated as needed. Calves were housed in pens equipped with 1 water tank/pen, and each tank was serviced by an individual water line to allow determination of pen drinking water disappearance. Water tank meters were validated at the beginning and end of the study, and were read daily and disappearance excluding water loss from tank cleaning (cleaned weekly) was calculated daily for each pen. Corn was steam-flaked approximately twice weekly to 0.36 kg/L bulk density after steaming for 40 min. Samples of diets and dietary ingredients were collected weekly, DM determined on a subsample, and the remaining sample was composited gravimetrically within treatment and diet. Composite diet samples were assayed for ash (6 h at 550°C), minerals (Method 9895.01; AOAC, 1990) , CP (Method 976.05; AOAC, 1990) , and ADF (Goering and Van Soest, 1970) . Weekly ingredient DM content was used to update as-fed diet composition each week.
Cattle health was visually evaluated twice daily for the first 2 wk and once daily thereafter. Cattle deemed unhealthy were pulled for further examination and diagnosis. Antibiotic treatment was given for bovine respiratory disease if rectal temperature exceeded 39.9°C, and cattle were returned to their home pen. The antibiotic used for the first incidence of respiratory disease was enrofloxacin (7.5 mg of enrofloxacin/kg of BW; Baytril 100; Bayer Animal Health, Shawnee Mission, KS). Florfenicol (40 mg of florfenicol/kg of BW; Nuflor; Merck Animal Health) was administered s.c. for the second incidence of respiratory disease, and the antibiotic used for the third and final incidence of respiratory disease was oxytetracycline (9 mg of oxytetracycline/kg of BW; Biomycin 200; Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO). Cattle determined to be noncompetitive (marked BW loss in the absence of BRD) or experiencing chronic health problems were removed from the study. One animal died during the experiment and 7 animals were determined to be noncompetitive or chronic and were removed from the study, and the performance data were calculated with these animals removed before analysis.
Experiment 2
Twenty Holstein bull calves, approximately 50 d of age, were purchased from a calf raiser near Dimmitt, TX, and delivered to the West Texas A&M University Research facility. Animals were processed on the day of arrival, and processing included ear tagging, vaccination for viral antigens (IBR, BVD type I and II, BRSV, and PI 3 ; Titanium 5; Agri Laboratories), vaccination against Mannheimia haemolytica and Pasteurella multocida (Once PMH; Merck Animal Health), administration of a clostridial bacterin-toxoid (Vision 7 with Spur; Merck Animal Health), and treatment for internal and external parasites (Ivomec Plus; Merial Ltd., Duluth, GA, and Safe-Guard, Merck Animal Health). Two weeks after arrival, calves were surgically castrated and were then allowed an additional 4 wk for recovery and acclimation to the facility. Steers were then housed in individual soilsurfaced pens, allowed ad libitum access to a 60% concentrate diet, and trained to lead over approximately 4 wk.
Fifteen steers were selected for the study, stratified by BW and ad libitum DMI, and randomized to 1 of 3 treatments. Treatments included ad libitum access to a 60% concentrate diet (Control), ad libitum access to Control + 200 g of Sucram/t of DM (Adlib), and Control + 200 g of Sucram/t of DM with feed offered paired to the intake of Control (Paired). Steers received treatments for at least 28 d in soil-surfaced individual pens before a 10-d metabolism period. During the metabolism period, steers were housed in metabolism crates (0.75 m × 1.76 m) for a 5-d acclimation period followed by a 5-d collection of feces and urine. Observations were collected over 3 different times because only 6 metabolism crates were available for use in the study. If a Paired animal in a block did not consume as much DM as the Control animal with which it was paired, feed intake of the Control animal was not reduced to be equal to the Paired animal because it would potentially exaggerate the relative response by Adlib.
The diet (Table 2 ) was formulated to be typical of starting diets for arriving calves in commercial feedlots in the southern Great Plains and was formulated to meet or exceed nutrient needs as described by NRC (2000) . A separate supplement containing Sucram in ground corn or ground corn only was applied as a top dress (equivalent to 1% of diet DM) as per treatment when feed was delivered and was mixed by hand. Samples of the diet and dietary ingredients were collected weekly for DM determination (24 h at 100°C), and DM content was used to update as-fed diet composition each week. During the 5-d collection of feces and urine, diet samples were collected daily and were composited gravimetrically within steer at the end of the collection period and stored at -20°C until analysis for CP (Method 988.05; AOAC, 1990) , ash (Method 942.05; AOAC, 1990), NDF (Vogel et al., 1999) , and ADF (Method 973.18; AOAC, 1990) . Total fecal output was collected every 24 h for 5 consecutive days into plastic containers (42 × 65 × 39 cm). Collected feces were weighed each day, thoroughly mixed, and an aliquot of 100 g was stored at -20°C until composited in a proportion relative to daily output within steer. Composite fecal samples were dried for 72 h at 60°C and were assayed for ash (Method 942.05; AOAC, 1990) , CP (Method 988.05; AOAC, 1990), and NDF (Vogel et al., 1999) .
Urine was collected every 24 h for 5 d into plastic containers (42 × 65 × 39 cm) containing 2 L of 3 M HCl to keep urine pH ≤ 2. Collected urine was mixed thoroughly, pH determined (Model 420A; Orion, Boston, MA), volume and weight were recorded, and an aliquot of 800 mL was refrigerated until composited in a proportion relative to daily output within steer and stored at -80°C until analysis. Acidified urine was assayed for several organic acids and monoamine metabolites by GC-MS as described by Shaw et al. (1995) .
Steers were fitted with indwelling jugular catheters (14 ga × 13.3 cm; Jorvet, Loveland, CO) before feeding on the fifth day of excreta collection. Blood samples (10 mL) were collected at 30-min intervals for 4 h (1 h before feeding and 3 h after feeding) to assay plasma AA. Postprandial samples for plasma AA were composited within steer and stored at -80°C until analysis by cation exchange chromatography with postcolumn derivatization with ninhydrin using a Beckman model 63100 (Beckman Instruments, Palo Alto, CA). At the same sampling times, whole blood (10 mL) was collected at 30-min intervals for 4 h (1 h before feeding and 3 h after feeding) for prolactin determination and at 15-min intervals for 4 h (1 h before feeding and 3 h after feeding) for serum insulin and growth hormone analyses. Serum hormone samples were allowed 30 min to clot at room temperature. Blood samples were centrifuged at 3,000 × g for 20 min at 4°C, and samples were stored at -80°C until hormone concentrations were determined by RIA. Serum growth hormone and prolactin were quantified by double antibody RIA as described by Hoefler and Hallford (1987) and Spoon and Hallford (1989) , respectively, using primary antisera and purified standard and iodination preparations supplied by the National Hormone and Peptide Program (Torrance, CA). Both growth hormone and prolactin were determined in single assays having intra-assay CV of 7.1 and 4.3%, respectively. Serum concentrations of insulin were determined by solid phase RIA using components of a commercial kit (Coat-A-Count; Siemens Medical Solutions Diagnostics, Los Angeles, CA) as described by Camacho et al. (2012) . Within and between assay CV for insulin determinations were 8.4 and 2.8%, respectively.
Statistical Analysis
Experiment 1. Feedlot performance data were analyzed as a randomized complete block using the Mixed procedure (SAS Inst. Inc., Cary, NC) with pen as the experimental unit. Responses across time were evaluated as repeated measures using the spatial power covariance matrix to accommodate unequal time spacing. When the treatment × time effect was not significant (P > 0.10), overall performance data were evaluated and the model included the fixed effect of treatment and the random effect of load. Means were separated using polynomial contrasts (linear, quadratic, and cubic), responses were declared significant when P < 0.10, and trends are indicated as 0.1 < P ≤ 0.15. Health data were evaluated by Chi-square analysis using the FREQ procedure of SAS. Fisher's exact test was used to accommodate the small numbers of observations/cell. Experiment 2. Data were analyzed as a randomized complete block design using the Mixed procedure of SAS. The model included the fixed effect of treatment and the random effect of block. Growth hormone data were summarized by Cluster analysis (Veldhuis and Johnson, 1986) , whereas insulin and prolactin data were summarized by calculating area under the curve using trapezoidal summation. Summarized data and remaining data were then subjected to ANOVA. Means were separated using preplanned contrasts of Adlib vs. Control and Paired vs. Control. Means were declared as different when P < 0.10, and trends are indicated as 0.1 < P ≤ 0.15.
RESULTS AND DISCUSSION

Experiment 1
Commercial sweeteners have been used successfully in the food and beverage industries as noncaloric sensory replacements for certain sugars. The product used in the present experiments (SUCRAM C-150) contains sodium saccharin and has been used commercially to increase feed intake by newly weaned pigs (Schegel and Hall, 2006; Schlegel et al., 2006; Sterk et al., 2008) . This study explored time-and dose-dependent responses to Sucram with newly-received, stressed calves.
The effects of treatment and time did not interact (P > 0.98) for growth performance (Fig. 1) , suggesting that the pattern of the response across time was similar among treatments. Overall, total BW gain (P > 0.16), ADG (P > 0.16), and G:F (P > 0.46) were similar among treatments (Table 3) . Overall, DMI responded cubically (P = 0.09) to increasing Sucram supplementation, with the greatest DMI for steers receiving 200 g of Sucram/t (17% greater for steers receiving 200 g of Sucram/t compared to steers fed the Control diet). Water disappearance responded quadratically (P = 0.06) and cubically (P = 0.02) to Sucram supplementation. Water disappearing per unit of DMI was linearly decreased (P = 0.07) as Sucram level increased in the diet. Feeding Sucram did not influence (P ≥ 0.47) the incidence of cattle treated once or retreated for respiratory disease.
The majority of data describing feed/food intake responses to sodium saccharin-based sweetener supplementation has been derived from preference tests with rats. A common model employed involves offering unsupplemented drinking water simultaneously with saccharin-supplemented water. Ramirez (1990) reported that rats fed "slurried" food supplemented with saccharin consumed approximately 12% more energy than rats not receiving saccharin, whereas the response to saccharin was not evident if rats were previously exposed to the same slurried diet without saccharin or if rats were allowed to consume saccharin-supplemented water before the saccharin-supplemented, slurried diet was offered. Tordoff (1988) indicated that rats consumed more food when drinking water was fortified with saccharin than when tap water served as the drinking water source.
More recently, a small number of beef cattle studies have been conducted under simulated production conditions. A study with Sucram at the University of Leeds reported increased feed intake (additive concentration not specified) and BW gain by heifer calves (averaging 14 d of age) through 3 and 6 wk, respectively (J. M. 
Experiment 2
Feed Intake and Apparent Digestibility. This study was designed to allow at least 28 d of adaptation to saccharin because results from Exp. 1 suggested that the 2 Cubic effect (P = 0.09).
3 Quadratic (P = 0.06) and cubic (P = 0.02) effect. 4 Linear effect (P = 0.07).
5 Chi-square statistics for measures of morbidity, P ≥ 0.47. DMI response stabilized after 21 d (Fig. 1, top) . One steer died of accidental causes during the period of study and data for this animal were excluded from analyses. Dry matter intake was not different (P = 0.34) for steers receiving Paired and Control (Table 4) ; however, steers receiving Adlib tended to consume more DM (P = 0.14) than steers fed Control (8%). The magnitude of numeric increase in DMI from Sucram was approximately 50% of the increase observed in Exp. 1. Fecal and urine excretion were not affected by treatment (P ≥ 0.15). The DM content of feces (23%) was similar to values discussed by Merchen (1988) . Average urine excretion in this experiment was 28 mL/kg of BW daily and falls within the range of normal values (Merchen, 1988) . Treatment did not alter (P ≥ 0.17) apparent total tract digestibility of DM, OM, CP, or NDF (Table 4) . Although a reduction in digestibility has been associated with increased DMI (Merchen, 1988) , it is likely that a larger difference in DMI by cattle is needed to detect reduced nutrient digestibility.
Plasma AA. The concentrations of leucine, valine, tyrosine, and phenylalanine were not altered by treatment (P > 0.54; Table 5 ). Neither the plasma tryptophan:branched chain AA ratio nor the tryptophan:large neutral AA ratio were altered by treatment (P > 0.34). However, tryptophan concentrations tended to be lower for steers receiving Adlib (P = 0.12) than steers fed Control. Tryptophan is the precursor of the neurotransmitter serotonin; therefore, serotonin production might be expected to be less for Adlib than for Control. Nevertheless, Fernstrom and Wurtman (1972) suggested that brain serotonin content might be influenced by factors beyond plasma tryptophan concentration alone. These authors determined a strong, positive correlation of 0.95 between brain tryptophan content and the plasma ratio of tryptophan:large neutral AA (valine, leucine, isoleucine, phenylalanine, and tyrosine), and a correlation of 0.89 between brain serotonin and the ratio of tryptophan:branched-chain AA in plasma. Among the large neutral AA, isoleucine, leucine, and valine are also known as branched-chain AA and have been shown to reduce tryptophan uptake into the brain (Trottier and Easter, 1995) . In addition, branched chain AA in plasma have also been considered indicators of protein absorption from the intestine (Dhiman and Satter, 1997) .
The concentration of citrulline and homocysteine were lower (P = 0.03) for Adlib steers compared to Control steers. Steers fed Paired also had lower plasma homocysteine concentration than steers fed Control (P = 0.01), whereas plasma citrulline concentration tended (P = 0.13) to be lower for Paired than for Control. Citrulline and homocysteine belong to the group of AA that are not present in proteins (Voet and Voet, 2004) . Citrulline is an important intermediate in urea synthesis, whereas homocysteine is an intermediate in the metabolism of methionine (Voet and Voet, 2004) . Low plasma citrulline concentrations have been used as a marker of intestinal failure in humans caused by unknown mechanisms (Crenn et al., 2000) . On the other hand, elevated concentration of homocysteine in plasma is related to cardiovascular disease and neural tube defects in hu- (Voet and Voet, 2004) . However, observations in this experiment are not expected to be related to pathological conditions. It is unclear at present what role Sucram may play in tending to reduce plasma citrulline and in reducing plasma homocysteine concentration. Monoamine Metabolites. Urine concentration of lactate, 3-indolacetic acid, methylsuccinic acid, homovanillic acid, and hippuric acid were not altered by treatment (P > 0.28; Table 6 ). However, urine concentration of ethylmalonic acid, vanillymandelic acid, and 5-hydroxyindolacetic acid were greater (P < 0.06) for steers receiving Adlib than for steers receiving Control; steers fed Paired had a greater (P = 0.02) urine concentration of vanillymandelic acid than steers fed Control.
A subset of the monoamine metabolites assayed was selected because they represent end products of neurotransmitter catabolism. Serotonin is primarily catabolized to 5-hydroxyindolacetic acid (Goldfarb and Wilk, 1976) , and 3-indole-acetic acid is suggested to be a metabolite produced by the β-oxidation of indole butyric acid, possibly via indole acetaldehyde (Jackson, 1929) . Vanillymandelic acid is the final metabolite in the catabolism of epinephrine and norepinephrine (Eisenhofer et al., 2004) . Homovanillic acid is the end product of dopamine catabolism mediated by the enzymes catechol-O-methyltransferase, monoamine oxidase, and aldehyde dehydrogenase (Goldfarb and Wilk, 1976) . Additionally, hippuric acid is the metabolite produced from benzoic acid in the liver, and it is an end product of dietary degradation of phenolic compounds in cattle (Dijkstra et al., 2013) . Ethylmalonic acid is an intermediate in fatty acid metabolism and serves as a biomarker of acyl-CoA-dehydrogenase deficiency in humans (Takken et al., 2005) .
The concentration of 5-hydroxyindolacetic acid was approximately double the value for urine samples from animals fed Sucram (Adlib or Paired) compared to Control. It is generally accepted that serotonin has an inhibitory effect on food intake, and one might expect reduced urine 5-hydroxyindolacetic acid concentration by Adlib and Paired steers. For example, administration of serotonin, and its precursor tryptophan, into the paraventricular nucleus of rats caused a 50% reduction in food intake (Fernstrom and Wurtman, 1972) . However, different findings have been described in ruminants. Baile et al. (1979) reported a dose-dependent increase in feed intake as the dose of serotonin injected intracranially increased. Markus et al. (2000) reported that a carbohydrate-rich diet elevated brain serotonin concentration in rats and Petr et al. (2006) reported a greater concentration of serotonin and 5-hydroxyindolacetic acid in the parabrachial nucleus of rats after drinking water containing saccharin. Results from the present experiment might indicate greater levels of serotonin in the body or increased serotonin turnover when Sucram was consumed. This might be regulated at the level of reuptake of serotonin in the vesicles of neurons and corroborate the findings of Baile et al. (1979) .
The catabolism of both epinephrine and norepinephrine gives rise to vanillymandelic acid, as described previously. Between these 2 catecholamines, norepinephrine has been most closely linked to dopamine in the control of feed intake (Wellman, 2005) . Norepinephrine has been reported to be both a suppressor and a stimulator of feed intake (Wellman, 2005) . Greater urine concentrations of vanillymandelic acid by steers receiving Sucram in this study might indicate greater rates of dopamine, epinephrine, or norepinephrine formation. Wise (2006) described dopamine as the primary neurotransmitter involved in food reinforcement in humans.
Ethylmalonic acid is involved in fatty acid metabolism (Lough and Calder, 1976) , and fatty acid metabolism has been related to the control of feed intake in mammals (Ronnett et al., 2006) . Lough and Calder (1976) studied urinary excretion of methylmalonic and ethylmalonic acids in sheep. These authors reported urine concentrations of 150 to 550 mg/L of ethylmalonic acid for the sheep fed 90% barley diets, whereas urine from sheep fed conventional diets (composition not reported) contained < 20 mg/L of ethylmalonic acid. Similar results have been reported by O'Harte et al. (1989) . These authors found a greater plasma ethylmalonic acid concentration for lambs fed the barley diet compared to Control animals. The greater concentrations of ethylmalonic acid in this experiment might indicate inhibition of fatty acid degradation and activation of lipid biosynthesis. Smith et al. (1992) found greater activities of fatty acid synthetase as DMI increased. There is evidence that inhibitors of fatty acid synthase can decrease food intake. Intraperitoneal injections of the cerelunin de- rivative, C75 (fatty acid synthetase inhibitor), abruptly cease feed intake within 1 h after injection in mice. The mechanism of action of this inhibitor seems to be related to interruptions in neuropeptide (neuropeptide Y, agoutirelated protein, proopiomelanocortin, and the cocaineand amphetamine-regulated transcript) signaling pathways in obese and lean mice (Shimokawa et al., 2001) . A reduction in feed intake has also been reported with stimulation of carnitine palmitoyltransferase-1, the enzyme that regulates fatty acid β-oxidation (Ronnett et al., 2006) . The mechanism of action, according to Ronnett et al. (2006) , seems to be mediated by modulation of an adenosine monophosphate-activated protein kinase. Hormone Profile. Serum prolactin concentrations and area under the prolactin curve (Table 5) were not affected by treatment (P ≥ 0.20), and there was no treatment × time interaction (P = 0.41). Prolactin was employed as an indirect indicator of opioid peptide action because opioids have been widely implicated in feed intake regulation (Obese et al., 2007) . Hart and Cowie (1978) reported that i.v. administration of the opioid agonist morphine (10 mg) in goats increased plasma prolactin concentration from 9 to 67 ng/ mL by 15 min after administration, whereas parenteral administration of an opioid antagonist, naloxone (1.2 mg), before treatment with morphine, inhibited the prolactin response to the opioid agonist. Opioids might increase plasma prolactin in calves primarily by affecting hypothalamic dopamine turnover and decreasing the level of dopamine in portal blood (Johnson et al., 1991) . Baile and Della-Fera (1984) mentioned an interaction between opioids and dopamine. Peripheral injections of morphine and intracerebroventricular injections of D-Ala 2 -D-Leu 5 -enkephalin elevated the dopamine metabolite 3, 4-dihydroxyphenylacetic acid in mouse striatum, indicating dopamine release (Urwyler and Tabakoff, 1981) . Physiological studies have elucidated a relationship between opioids and the initiation of feeding (Baile and Della-Fera, 1984) . Continuous infusion over 90 min of 26, 51, and 102 nmoles/min of the D-ala 2 -met-enkephalinamide (opiate agonist) into the lateral cerebral ventricle increased food intake of satiated sheep (Baile et al., 1981) , and peripheral injections of naloxone decreased food intake for up to 90 min at different doses in sheep that were previously fasted for 4 h (Baile et al., 1981) . Subcutaneous injection of 0.5 mg/kg of BW of naltrexone in rats decreased caloric intake by 50% when animals consumed highly palatable food (Apfelbaum and Mandenoff, 1981) . These authors suggested that palatability of food activates the opioid system rather than its energy content. Results from our experiment do not suggest opioid involvement when Sucram is fed.
Serum insulin concentration and area under the insulin curve (Table 5 ) was greater for Adlib steers than for Control steers (P = 0.04). Additionally, Paired steers tended to have a greater concentration and area under the curve than Control steers (P < 0.14). However, growth hormone area under the curve, mean concentration, mean nadir, peak height, and peak interval were not different between treatments (P > 0.30; data not shown). The tendency for greater insulin area for Paired steers might suggest a small sweetener-specific effect on insulin release. Injection of a different artificial sweetener (Acesulfame K) into the right cervical vein (150 mg/kg of BW) has increased plasma insulin concentration in a dose-dependent manner within 5 min after injection (Liang et al., 1987) . Similar results were observed with infusion of glucose by these authors. Malaisse et al. (1998) reported that sodium saccharin at 10 mM promoted insulin release (140.1 μU/(islet•90 min)) from isolated pancreatic islets in rats. The G protein-coupled receptors for sweeteners present in islets cells might explain this mechanism of action (Malaisse et al., 1998) .
Further research in rats suggests that a relationship may exist between monoamines and cephalic-phase insulin release. Holmes et al. (1989) reported a positive relationship between insulin concentration and monoamine concentrations in rats. Approximately 64% of the variation in insulin release was attributed to serotonin. Therefore, greater concentrations of insulin might be expected with greater serotonin secretion. Additionally, greater insulin concentrations in animals receiving Sucram might denote facilitation of fatty acid synthesis in conjunction with the biomarker ethylmalonic acid described before.
Feeding Sucram to newly-received, stressed calves at 200 g/t of DM increased feed intake under the conditions of the study, but this response did not translate into a reduction in morbidity. The intake response was related to a sweetener-specific increase in urinary 5-hydroxyindolacetic acid and vanillymandelic acid concentration, suggesting potential alterations in the turnover of catecholamines.
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